Zoetis Inc

US

ZTS

Health Care

145.54 ₽

Current price

Buy
145.54 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    447 / 1328

  • Position in country

    3476 / 14179

  • Return on Assets, %

    16.6

    -2.7

  • Net income margin, %

    23.6

    2.8

  • EBITDA margin, %

    38

    10.8

  • Debt to Equity, %

    131.4

    19.2

  • Intangible assets and goodwill, %

    28.6

    3.6

  • Revenue CAGR 3Y, %

    8.5

    8.5

  • Total Equity change 1Y, %

    13.4

    0

  • Revenue Y, % chg

    5.7

    0.5

  • P/E

    29.5

    22.7

  • P/BV

    13.7

    1.5

  • P/S

    8

    2.3

  • EV/S

    8.5

    2.4

  • EV/EBITDA

    20.3

    7.4

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    49.3

    51.3

  • Forward P/E

    25

    15.6

  • Dividend Yield, %

    1.1

    1.7

  • Forward Dividend Yield, %

    1.1

    0.2

  • Expected dividend per share

    1.7

    0

  • Payout Ratio, %

    30.5

    30.3

  • Dividend Ex Date

    2024-04-18

Get an analytical review of this company

Competitors

Ranks

  • Royalty Pharma PLC

    00%

  • Zoetis Inc

    00%

  • Eli Lilly and Co

    00%

  • Bristol-Myers Squibb Co

    00%

  • Elanco Animal Health Inc

    00%

  • Johnson & Johnson

    00%

  • Viatris Inc

    00%

  • Merck & Co Inc

    00%

  • Pfizer Inc

    00%

  • Catalent Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    68670.9

  • Ticker

    ZTS.N

  • ISIN

    US98978V1035

  • IPO date

    2013-02-01

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-13

  • Date fact. publication of reports

    2023-12-31

Company Description

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.